{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:26:45Z","timestamp":1771266405080,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s13277-015-4013-y","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T19:15:19Z","timestamp":1441653319000},"page":"2119-2126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Seyed Mohammad Hossein","family":"Kashfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faegheh","family":"Behboudi Farahbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Nazemalhosseini Mojarad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Mashayekhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Azimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Romani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaghayegh","family":"Derakhshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Malekpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Asadzadeh Aghdaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,7]]},"reference":[{"issue":"9","key":"4013_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.6004\/jnccn.2008.0067","volume":"6","author":"QP Ly","year":"2008","unstructured":"Ly QP, Sasson AR. Modern surgical considerations for gastric cancer. J Natl Compr Cancer Netw. 2008;6(9):885\u201394.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"4013_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10\u201329. doi: 10.3322\/caac.20138 .","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4013_CR3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/gut.2009.191080","volume":"59","author":"J Steevens","year":"2010","unstructured":"Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59(1):39\u201348. doi: 10.1136\/gut.2009.191080 .","journal-title":"Gut"},{"issue":"11","key":"4013_CR4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","volume":"345","author":"N Uemura","year":"2001","unstructured":"Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784\u20139. doi: 10.1056\/NEJMoa001999 .","journal-title":"N Engl J Med"},{"issue":"5","key":"4013_CR5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/sj.bjc.6603893","volume":"97","author":"NY Sung","year":"2007","unstructured":"Sung NY, Choi KS, Park EC, Park K, Lee SY, Lee AK, et al. Smoking, alcohol and gastric cancer risk in Korean men: the National Health Insurance Corporation Study. Br J Cancer. 2007;97(5):700\u20134. doi: 10.1038\/sj.bjc.6603893 .","journal-title":"Br J Cancer"},{"issue":"13","key":"4013_CR6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321. doi: 10.1200\/jco.2010.33.0597 .","journal-title":"J Clin Oncol"},{"issue":"9813","key":"4013_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321. doi: 10.1016\/s0140-6736(11)61873-4 .","journal-title":"Lancet"},{"issue":"1","key":"4013_CR8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/14737140.9.1.135","volume":"9","author":"PA Kovoor","year":"2009","unstructured":"Kovoor PA, Hwang J. Treatment of resectable gastric cancer: current standards of care. Expert Rev Anticancer Ther. 2009;9(1):135\u201342. doi: 10.1586\/14737140.9.1.135 .","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9688","key":"4013_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","volume":"374","author":"HH Hartgrink","year":"2009","unstructured":"Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477\u201390. doi: 10.1016\/s0140-6736(09)60617-6 .","journal-title":"Lancet"},{"issue":"4","key":"4013_CR10","first-page":"371","volume":"20","author":"P Azimzadeh","year":"2011","unstructured":"Azimzadeh P, Romani S, Mohebbi SR, Kazemian S, Vahedi M, Almasi S, et al. Interleukin-16 (IL-16) gene polymorphisms in Iranian patients with colorectal cancer. J Gastrointestin Liver Dis. 2011;20(4):371\u20136.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"10","key":"4013_CR11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cancergen.2012.05.013","volume":"205","author":"P Azimzadeh","year":"2012","unstructured":"Azimzadeh P, Romani S, Mohebbi SR, Mahmoudi T, Vahedi M, Fatemi SR, et al. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genet. 2012;205(10):501\u20137. doi: 10.1016\/j.cancergen.2012.05.013 .","journal-title":"Cancer Genet"},{"key":"4013_CR12","doi-asserted-by":"crossref","unstructured":"Romani S, Hosseini SM, Mohebbi SR, Kazemian S, Derakhshani S, Khanyaghma M et al. Interleukin-16 gene polymorphisms are considerable host genetic factors for patients\u2019 susceptibility to chronic hepatitis B infection. 2014; 2014:790753. doi: 10.1155\/2014\/790753 .","DOI":"10.1155\/2014\/790753"},{"issue":"6","key":"4013_CR13","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.4049\/jimmunol.128.6.2563","volume":"128","author":"DM Center","year":"1982","unstructured":"Center DM, Cruikshank W. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol (Baltimore, Md: 1950). 1982;128(6):2563\u20138.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"2","key":"4013_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/IGC.0b013e318236a27b","volume":"22","author":"A Yellapa","year":"2012","unstructured":"Yellapa A, Bahr JM, Bitterman P, Abramowicz JS, Edassery SL, Penumatsa K, et al. Association of interleukin 16 with the development of ovarian tumor and tumor-associated neoangiogenesis in laying hen model of spontaneous ovarian cancer. Int J Gynecol Cancer. 2012;22(2):199\u2013207. doi: 10.1097\/IGC.0b013e318236a27b .","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl 2","key":"4013_CR15","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1002\/ibd.20677","volume":"14","author":"D Fina","year":"2008","unstructured":"Fina D, Pallone F. What is the role of cytokines and chemokines in IBD? Inflamm Bowel Dis. 2008;14 Suppl 2:S117\u20138. doi: 10.1002\/ibd.20677 .","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"4013_CR16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2567.2000.00997.x","volume":"100","author":"NL Mathy","year":"2000","unstructured":"Mathy NL, Scheuer W, Lanzendorfer M, Honold K, Ambrosius D, Norley S, et al. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology. 2000;100(1):63\u20139.","journal-title":"Immunology"},{"issue":"1","key":"4013_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/B:CLIN.0000017181.01474.35","volume":"21","author":"Y Mochizuki","year":"2004","unstructured":"Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, et al. TNF-\u03b1 promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis. 2004;21(1):39\u201347.","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"4013_CR18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.10269","volume":"83","author":"YC Chung","year":"2003","unstructured":"Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol. 2003;83(4):222\u20136. doi: 10.1002\/jso.10269 .","journal-title":"J Surg Oncol"},{"issue":"4","key":"4013_CR19","first-page":"529","volume":"25","author":"LN Shanmugham","year":"2006","unstructured":"Shanmugham LN, Petrarca C, Frydas S, Donelan J, Castellani ML, Boucher W, et al. IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. J Exp Clin Cancer Res. 2006;25(4):529\u201336.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1\u20132","key":"4013_CR20","first-page":"132","volume":"409","author":"LB Gao","year":"2009","unstructured":"Gao LB, Liang WB, Xue H, Rao L, Pan XM, Lv ML, et al. Genetic polymorphism of interleukin-16 and risk of nasopharyngeal carcinoma. Clin Chim Acta. 2009;409(1\u20132):132\u20135. doi: 10.1016\/j.cca.2009.09.017 .","journal-title":"Clin Chim Acta"},{"issue":"8","key":"4013_CR21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1442-2042.2010.02559.x","volume":"17","author":"J Zhu","year":"2010","unstructured":"Zhu J, Qin C, Yan F, Wang M, Ding Q, Zhang Z, et al. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population. Int J Urol. 2010;17(8):700\u20137.","journal-title":"Int J Urol"},{"issue":"3","key":"4013_CR22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/gtmb.2013.0386","volume":"18","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Tao L, Wang B, Nie P, Tang Y, Zhu M. Interleukin-16 gene polymorphisms rs4778889, rs4072111, rs11556218, and cancer risk in Asian populations: a meta-analysis. Genet Test Mol Biomarkers. 2014;18(3):174\u201382. doi: 10.1089\/gtmb.2013.0386 .","journal-title":"Genet Test Mol Biomarkers"},{"issue":"9","key":"4013_CR23","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.7314\/APJCP.2013.14.9.5269","volume":"14","author":"T Zhang","year":"2013","unstructured":"Zhang T, Wang H. Variants of interleukin-16 associated with gastric cancer risk. Asian Pac J Cancer Prev. 2013;14(9):5269\u201373.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"4013_CR24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/gtmb.2014.0170","volume":"18","author":"QS Luo","year":"2014","unstructured":"Luo QS, Wang JL, Deng YY, Huang HD, Fu HD, Li CY, et al. Interleukin-16 polymorphism is associated with an increased risk of glioma. Genet Test Mol Biomarkers. 2014;18(10):711\u20134. doi: 10.1089\/gtmb.2014.0170 .","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"4013_CR25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.91","volume":"40","author":"G Thomas","year":"2008","unstructured":"Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40(3):310\u20135. doi: 10.1038\/ng.91 .","journal-title":"Nat Genet"},{"issue":"15","key":"4013_CR26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/pros.21197","volume":"70","author":"E Comperat","year":"2010","unstructured":"Comperat E, Roupret M, Drouin SJ, Camparo P, Bitker MO, Houlgatte A, et al. Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy. Prostate. 2010;70(15):1622\u20137. doi: 10.1002\/pros.21197 .","journal-title":"Prostate"},{"issue":"4","key":"4013_CR27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/pcan.2013.36","volume":"16","author":"L Hughes","year":"2013","unstructured":"Hughes L, Ruth K, Rebbeck TR, Giri VN. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men. Prostate Cancer Prostatic Dis. 2013;16(4):308\u201314. doi: 10.1038\/pcan.2013.36 .","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"4013_CR28","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s13277-013-1257-2","volume":"35","author":"X Qin","year":"2014","unstructured":"Qin X, Peng Q, Lao X, Chen Z, Lu Y, Lao X, et al. The association of interleukin-16 gene polymorphisms with IL-16 serum levels and risk of nasopharyngeal carcinoma in a Chinese population. Tumour Biol. 2014;35(3):1917\u201324. doi: 10.1007\/s13277-013-1257-2 .","journal-title":"Tumour Biol"},{"issue":"2","key":"4013_CR29","first-page":"295","volume":"30","author":"LB Gao","year":"2009","unstructured":"Gao LB, Rao L, Wang YY, Liang WB, Li C, Xue H, et al. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis. 2009;30(2):295\u20139. doi: 10.1093\/carcin\/bgn281 .","journal-title":"Carcinogenesis"},{"issue":"3","key":"4013_CR30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4013_CR31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399. doi: 10.1016\/j.cell.2010.01.025 .","journal-title":"Cell"},{"issue":"1\u20132","key":"4013_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2008.03.002","volume":"659","author":"JK Kundu","year":"2008","unstructured":"Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res. 2008;659(1\u20132):15\u201330. doi: 10.1016\/j.mrrev.2008.03.002 .","journal-title":"Mutat Res"},{"issue":"1\u20132","key":"4013_CR33","first-page":"10","volume":"20","author":"M Muc-Wierzgon","year":"2006","unstructured":"Muc-Wierzgon M, Nowakowska-Zajdel E, Kokot T, Kozowicz A, Wiczkowski A, Grochowska-Niedworok E, et al. Genetic dysregulation of TNF alpha and TNF alpha type II receptors in colon cancer at the II and III stage of disease. J Biol Regul Homeost Agents. 2006;20(1\u20132):10\u20134.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"2a","key":"4013_CR34","first-page":"709","volume":"25","author":"H Kai","year":"2005","unstructured":"Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res. 2005;25(2a):709\u201313.","journal-title":"Anticancer Res"},{"issue":"8","key":"4013_CR35","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1078-0432.CCR-07-4045","volume":"14","author":"FM Speetjens","year":"2008","unstructured":"Speetjens FM, Kuppen PJ, Sandel MH, Menon AG, Burg D, van de Velde CJ, et al. Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients. Clin Cancer Res. 2008;14(8):2276\u201384. doi: 10.1158\/1078-0432.ccr-07-4045 .","journal-title":"Clin Cancer Res"},{"issue":"10","key":"4013_CR36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1593\/neo.07559","volume":"9","author":"O Kollmar","year":"2007","unstructured":"Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling MK, et al. Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia (New York, NY). 2007;9(10):862\u201370.","journal-title":"Neoplasia (New York, NY)"},{"issue":"8","key":"4013_CR37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jir.2006.26.511","volume":"26","author":"WG Glass","year":"2006","unstructured":"Glass WG, Sarisky RT, Vecchio AM. Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interf Cytokine Res. 2006;26(8):511\u201320. doi: 10.1089\/jir.2006.26.511 .","journal-title":"J Interf Cytokine Res"},{"issue":"6","key":"4013_CR38","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.155.6.2902","volume":"155","author":"S Laberge","year":"1995","unstructured":"Laberge S, Cruikshank WW, Kornfeld H, Center DM. Histamine-induced secretion of lymphocyte chemoattractant factor from CD8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol (Baltimore, Md : 1950). 1995;155(6):2902\u201310.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"2","key":"4013_CR39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2567.2000.00959.x","volume":"99","author":"V Sharma","year":"2000","unstructured":"Sharma V, Sparks JL, Vail JD. Human B-cell lines constitutively express and secrete interleukin-16. Immunology. 2000;99(2):266\u201371.","journal-title":"Immunology"},{"issue":"6","key":"4013_CR40","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4049\/jimmunol.159.6.2904","volume":"159","author":"V Rumsaeng","year":"1997","unstructured":"Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol (Baltimore, Md : 1950). 1997;159(6):2904\u201310.","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"10","key":"4013_CR41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0167-5699(96)10052-I","volume":"17","author":"DM Center","year":"1996","unstructured":"Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today. 1996;17(10):476\u201381.","journal-title":"Immunol Today"},{"issue":"13","key":"4013_CR42","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djs257","volume":"104","author":"D Atanackovic","year":"2012","unstructured":"Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J, et al. Role of interleukin 16 in multiple myeloma. J Natl Cancer Inst. 2012;104(13):1005\u201320. doi: 10.1093\/jnci\/djs257 .","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"4013_CR43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0145-2126(01)00192-8","volume":"26","author":"M Koike","year":"2002","unstructured":"Koike M, Sekigawa I, Okada M, Matsumoto M, Iida N, Hashimoto H, et al. Relationship between CD4(+)\/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16. Leuk Res. 2002;26(8):705\u201311.","journal-title":"Leuk Res"},{"issue":"2","key":"4013_CR44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.10444","volume":"75","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Kyriakou DS, Christophoridou AV, Perisinakis K, Hatzivasili A, et al. Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity. Am J Hematol. 2004;75(2):101\u20136. doi: 10.1002\/ajh.10444 .","journal-title":"Am J Hematol"},{"issue":"1","key":"4013_CR45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00005-007-0003-0","volume":"55","author":"M Liebrich","year":"2007","unstructured":"Liebrich M, Guo LH, Schluesener HJ, Schwab JM, Dietz K, Will BE, et al. Expression of interleukin-16 by tumor-associated macrophages\/activated microglia in high-grade astrocytic brain tumors. Arch Immunol Ther Exp. 2007;55(1):41\u20137. doi: 10.1007\/s00005-007-0003-0 .","journal-title":"Arch Immunol Ther Exp"},{"issue":"19 Supplement","key":"4013_CR46","doi-asserted-by":"crossref","first-page":"A64-A","DOI":"10.1158\/1078-0432.OVCA13-A64","volume":"19","author":"A Yellapa","year":"2013","unstructured":"Yellapa A, Bitterman P, Abramowicz JS, Bahr JM, Sharma S, Basu S, et al. Abstract A64: association of interleukin 16 with early metastasis of ovarian tumors. Clin Cancer Res. 2013;19(19 Supplement):A64-A.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"4013_CR47","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1158\/1078-0432.CCR-08-1199","volume":"14","author":"Y Horikawa","year":"2008","unstructured":"Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res. 2008;14(23):7956\u201362. doi: 10.1158\/1078-0432.ccr-08-1199 .","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4013_CR48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cell.2004.11.022","volume":"119","author":"GL Bond","year":"2004","unstructured":"Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004;119(5):591\u2013602. doi: 10.1016\/j.cell.2004.11.022 .","journal-title":"Cell"},{"issue":"7","key":"4013_CR49","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-09-3541","volume":"70","author":"MS Nicoloso","year":"2010","unstructured":"Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010;70(7):2789\u201398. doi: 10.1158\/0008-5472.can-09-3541 .","journal-title":"Cancer Res"},{"issue":"2","key":"4013_CR50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ygyno.2013.12.030","volume":"132","author":"X-D Xiong","year":"2014","unstructured":"Xiong X-D, Luo X-P, Cheng J, Liu X, Li E-M, Zeng L-Q. A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women. Gynecol Oncol. 2014;132(2):450\u20134.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4013_CR51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1158\/0008-5472.CAN-14-2101","volume":"75","author":"BM Ryan","year":"2015","unstructured":"Ryan BM, Robles AI, McClary AC, Haznadar M, Bowman ED, Pine SR, et al. Identification of a functional SNP in the 3\u2032 UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res. 2015;75(3):566\u201375.","journal-title":"Cancer Res"},{"issue":"1","key":"4013_CR52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13277-013-1034-2","volume":"35","author":"X-F Zeng","year":"2014","unstructured":"Zeng X-F, Li J, Li S-B. A functional polymorphism in IL-1A gene is associated with a reduced risk of gastric cancer. Tumor Biol. 2014;35(1):265\u20138.","journal-title":"Tumor Biol"},{"issue":"3","key":"4013_CR53","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7314\/APJCP.2015.16.3.889","volume":"16","author":"S Haque","year":"2014","unstructured":"Haque S, Akhter N, Lohani M, Ali A, Mandal R. Matrix metalloproteinase-2-1306 C\u2009>\u2009T gene polymorphism is associated with reduced risk of cancer: a meta-analysis. Asian Pac J Cancer Prev. 2014;16(3):889\u201396.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"4013_CR54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7150\/jca.8594","volume":"5","author":"A Zaanan","year":"2014","unstructured":"Zaanan A, Dalban C, Emile J-F, Blons H, Fl\u00e9jou J-F, Goumard C, et al. ERCC1, XRCC1 and GSTP1 single nucleotide polymorphisms and survival of patients with colon cancer receiving oxaliplatin-based adjuvant chemotherapy. J Cancer. 2014;5(6):425.","journal-title":"J Cancer"},{"issue":"1","key":"4013_CR55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/0284186X.2013.770600","volume":"53","author":"B Beuselinck","year":"2014","unstructured":"Beuselinck B, Karadimou A, Lambrechts D, Claes B, Wolter P, Couchy G, et al. VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib\u2014a multicentric retrospective analysis. Acta Oncol. 2014;53(1):103\u201312.","journal-title":"Acta Oncol"},{"issue":"4","key":"4013_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drup.2014.10.003","volume":"17","author":"JC Mijn van der","year":"2014","unstructured":"van der Mijn JC, Mier JW, Broxterman HJ, Verheul HM. Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms. Drug Resist Updat. 2014;17(4):77\u201388.","journal-title":"Drug Resist Updat"},{"issue":"5","key":"4013_CR57","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00432-014-1859-0","volume":"141","author":"KS Leifler","year":"2015","unstructured":"Leifler KS, Asklid A, Fornander T, Askmalm MS. The RAD51 135G\u2009>\u2009C polymorphism is related to the effect of adjuvant therapy in early breast cancer. J Cancer Res Clin Oncol. 2015;141(5):797\u2013804.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"4013_CR58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","volume":"210","author":"S Bibert","year":"2013","unstructured":"Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, et al. IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction. J Exp Med. 2013;210(6):1109\u201316.","journal-title":"J Exp Med"},{"issue":"3","key":"4013_CR59","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.3892\/mmr.2015.3968","volume":"12","author":"B Zhang","year":"2015","unstructured":"Zhang B, Wang A, Xia C, Lin Q, Chen C. A single nucleotide polymorphism in primary-microRNA-146a reduces the expression of mature microRNA-146a in patients with Alzheimer\u2019s disease and is associated with the pathogenesis of Alzheimer\u2019s disease. Mol Med Rep. 2015;12(3):4037\u201342.","journal-title":"Mol Med Rep"},{"issue":"4","key":"4013_CR60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/tpj.2010.28","volume":"11","author":"D Wang","year":"2011","unstructured":"Wang D, Guo Y, Wrighton S, Cooke G, Sadee W. Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J. 2011;11(4):274\u201386.","journal-title":"Pharmacogenomics J"},{"issue":"7","key":"4013_CR61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12032-014-0030-8","volume":"31","author":"B Pang","year":"2014","unstructured":"Pang B, Sun SP, Gao L, Zhu RL, Zhang LX, An C, et al. A single nucleotide polymorphism in PIK3CA gene is inversely associated with P53 protein expression in breast cancer. Med Oncol (Northwood, London, England). 2014;31(7):30. doi: 10.1007\/s12032-014-0030-8 .","journal-title":"Med Oncol (Northwood, London, England)"},{"issue":"7","key":"4013_CR62","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10620-010-1557-y","volume":"56","author":"BS He","year":"2011","unstructured":"He BS, Pan YQ, Xu YF, Zhu C, Qu LL, Wang SK. Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population. Dig Dis Sci. 2011;56(7):2017\u201323. doi: 10.1007\/s10620-010-1557-y .","journal-title":"Dig Dis Sci"},{"issue":"4","key":"4013_CR63","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.7314\/APJCP.2013.14.4.2577","volume":"14","author":"XF Pan","year":"2013","unstructured":"Pan XF, Yang SJ, Loh M, Xie Y, Wen YY, Tian Z, et al. Interleukin-10 gene promoter polymorphisms and risk of gastric cancer in a Chinese population: single nucleotide and haplotype analyses. Asian Pac J Cancer Prev. 2013;14(4):2577\u201382.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"4013_CR64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00535-003-1315-4","volume":"39","author":"KA Lee","year":"2004","unstructured":"Lee KA, Ki CS, Kim HJ, Sohn KM, Kim JW, Kang WK, et al. Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J Gastroenterol. 2004;39(5):429\u201333. doi: 10.1007\/s00535-003-1315-4 .","journal-title":"J Gastroenterol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4013-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4013-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T21:10:27Z","timestamp":1691961027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,7]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["4013"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4013-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,7]]}}}